ADMA Biologics, Inc. Reports First Quarter 2013 Financial and Operational Results

Published: May 15, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ADMA Biologics, Inc. (ADMA), a specialty immune globulin company that develops, manufactures and intends to market plasma-based biologics for the treatment and prevention of certain infectious diseases, today reported financial and operational results for the quarter ended March 31, 2013.

Help employers find you! Check out all the jobs and post your resume.

Back to news